• Mangoceuticals filed a Form 12b-25 to delay its Form 10-Q for quarter ended March 31, 2026.
• Filing missed prescribed deadline as auditor required more time to complete review.
• Company expects to file report within 5 calendar days of original due date.
• Notice flagged no anticipated significant change in results of operations versus prior-year period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-023883), on May 15, 2026, and is solely responsible for the information contained therein.